Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

Lindsay B Kilburn; Dong-Anh Khuong-Quang; Jordan R Hansford; Daniel Landi; Jasper van der Lugt; Sarah E S Leary; Pablo Hernáiz Driever; Simon Bailey; Sébastien Perreault; Geoffrey McCowage; Angela J Waanders; David S Ziegler; Olaf Witt; Patricia A Baxter; Hyoung Jin Kang; Timothy E Hassall; Jung Woo Han; Darren Hargrave; Andrea T Franson; Michal Yalon Oren; Helen Toledano; Valérie Larouche; Cassie Kline; Mohamed S Abdelbaki; Nada Jabado; Nicholas G Gottardo; Nicolas U Gerber; Nicholas S Whipple; Devorah Segal; Susan N Chi; Liat Oren; Enrica E K Tan; Sabine Mueller; Izzy Cornelio; Lisa McLeod; Xin Zhao; Ashley Walter; Daniel Da Costa; Peter Manley; Samuel C Blackman; Roger J Packer; Karsten Nysom

doi:10.1038/s41591-024-02910-1

Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

Lindsay B Kilburn^*, Dong-Anh Khuong-Quang, Jordan R Hansford, Daniel Landi, Jasper van der Lugt, Sarah E S Leary, Pablo Hernáiz Driever, Simon Bailey, Sébastien Perreault, Geoffrey McCowage, Angela J Waanders, David S Ziegler, Olaf Witt, Patricia A Baxter, Hyoung Jin Kang, Timothy E Hassall, Jung Woo Han, Darren Hargrave, Andrea T Franson, Michal Yalon OrenHelen Toledano, Valérie Larouche, Cassie Kline, Mohamed S Abdelbaki, Nada Jabado, Nicholas G Gottardo, Nicolas U Gerber, Nicholas S Whipple, Devorah Segal, Susan N Chi, Liat Oren, Enrica E K Tan, Sabine Mueller, Izzy Cornelio, Lisa McLeod, Xin Zhao, Ashley Walter, Daniel Da Costa, Peter Manley, Samuel C Blackman, Roger J Packer, Karsten Nysom

^*Corresponding author for this work

Department of Paediatrics and Adolescent Medicine

Original language	English
Publication date	May 2024
Edition	5
Volume	30
Number of pages	1
DOIs	https://doi.org/10.1038/s41591-024-02910-1
Publication status	Published - May 2024

Series	Nature Medicine
ISSN	1078-8956

Access to Document

10.1038/s41591-024-02910-1Licence: CC BY

Cite this

Kilburn, L. B., Khuong-Quang, D.-A., Hansford, J. R., Landi, D., van der Lugt, J., Leary, S. E. S., Driever, P. H., Bailey, S., Perreault, S., McCowage, G., Waanders, A. J., Ziegler, D. S., Witt, O., Baxter, P. A., Kang, H. J., Hassall, T. E., Han, J. W., Hargrave, D., Franson, A. T., ... Nysom, K. (2024, May). Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial. (5 ed.) Nature Medicine https://doi.org/10.1038/s41591-024-02910-1

Kilburn, LB, Khuong-Quang, D-A, Hansford, JR, Landi, D, van der Lugt, J, Leary, SES, Driever, PH, Bailey, S, Perreault, S, McCowage, G, Waanders, AJ, Ziegler, DS, Witt, O, Baxter, PA, Kang, HJ, Hassall, TE, Han, JW, Hargrave, D, Franson, AT, Yalon Oren, M, Toledano, H, Larouche, V, Kline, C, Abdelbaki, MS, Jabado, N, Gottardo, NG, Gerber, NU, Whipple, NS, Segal, D, Chi, SN, Oren, L, Tan, EEK, Mueller, S, Cornelio, I, McLeod, L, Zhao, X, Walter, A, Da Costa, D, Manley, P, Blackman, SC, Packer, RJ & Nysom, K 2024, Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.. https://doi.org/10.1038/s41591-024-02910-1

@misc{2f0c98365896470cb8369cc40a43d0ef,

title = "Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial",

author = "Kilburn, {Lindsay B} and Dong-Anh Khuong-Quang and Hansford, {Jordan R} and Daniel Landi and {van der Lugt}, Jasper and Leary, {Sarah E S} and Driever, {Pablo Hern{\'a}iz} and Simon Bailey and S{\'e}bastien Perreault and Geoffrey McCowage and Waanders, {Angela J} and Ziegler, {David S} and Olaf Witt and Baxter, {Patricia A} and Kang, {Hyoung Jin} and Hassall, {Timothy E} and Han, {Jung Woo} and Darren Hargrave and Franson, {Andrea T} and {Yalon Oren}, Michal and Helen Toledano and Val{\'e}rie Larouche and Cassie Kline and Abdelbaki, {Mohamed S} and Nada Jabado and Gottardo, {Nicholas G} and Gerber, {Nicolas U} and Whipple, {Nicholas S} and Devorah Segal and Chi, {Susan N} and Liat Oren and Tan, {Enrica E K} and Sabine Mueller and Izzy Cornelio and Lisa McLeod and Xin Zhao and Ashley Walter and {Da Costa}, Daniel and Peter Manley and Blackman, {Samuel C} and Packer, {Roger J} and Karsten Nysom",

year = "2024",

month = may,

doi = "10.1038/s41591-024-02910-1",

language = "English",

volume = "30",

series = "Nature Medicine",

publisher = "Nature Publishing Group",

edition = "5",

type = "Other",

}

TY - GEN

T1 - Author Correction

T2 - The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

AU - Kilburn, Lindsay B

AU - Khuong-Quang, Dong-Anh

AU - Hansford, Jordan R

AU - Landi, Daniel

AU - van der Lugt, Jasper

AU - Leary, Sarah E S

AU - Driever, Pablo Hernáiz

AU - Bailey, Simon

AU - Perreault, Sébastien

AU - McCowage, Geoffrey

AU - Waanders, Angela J

AU - Ziegler, David S

AU - Witt, Olaf

AU - Baxter, Patricia A

AU - Kang, Hyoung Jin

AU - Hassall, Timothy E

AU - Han, Jung Woo

AU - Hargrave, Darren

AU - Franson, Andrea T

AU - Yalon Oren, Michal

AU - Toledano, Helen

AU - Larouche, Valérie

AU - Kline, Cassie

AU - Abdelbaki, Mohamed S

AU - Jabado, Nada

AU - Gottardo, Nicholas G

AU - Gerber, Nicolas U

AU - Whipple, Nicholas S

AU - Segal, Devorah

AU - Chi, Susan N

AU - Oren, Liat

AU - Tan, Enrica E K

AU - Mueller, Sabine

AU - Cornelio, Izzy

AU - McLeod, Lisa

AU - Zhao, Xin

AU - Walter, Ashley

AU - Da Costa, Daniel

AU - Manley, Peter

AU - Blackman, Samuel C

AU - Packer, Roger J

AU - Nysom, Karsten

PY - 2024/5

Y1 - 2024/5

U2 - 10.1038/s41591-024-02910-1

DO - 10.1038/s41591-024-02910-1

M3 - Other contribution

C2 - 38467878

VL - 30

T3 - Nature Medicine

ER -